This report from Life Science Intelligence provides the latest market data for the Global Peripheral Vascular Guidewires Market. Information covered by this report includes:
· unit volumes & pricing forecast from 2019-2024
· analyses of the leading companies, and
· global market share analysis.
The global market for peripheral vascular guidewires was valued at an estimated $107.4 million in 2020 and is projected to increase at a CAGR (2020-2024) of 9.7%. Product segments covered by this report include guidewires intended for use in transcatheter peripheral vascular diagnostic and interventional procedures.
This report covers the impact of COVID-19 on the peripheral vascular guidewires market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Boston Scientific, Cardinal Health, and others. The report provides insights into trends, drivers, and limiters of the peripheral vascular guidewires market, as well as highlights potential opportunities.
The peripheral vascular guidewires market was negatively impacted by the COVID-19 pandemic. The pandemic has affected elective surgical procedures markedly, as many non-critical procedures have been cancelled or postponed so that healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients.
Boston Scientific and Cardinal Health held an estimated market share of approximately 80% of the global peripheral vascular guidewires market. Abbott, Medtronic, and Asahi are the other companies with significant market share. Teleflex, after its acquisition of Vascular Solutions, and Merit Medical are companies that are making rapid inroads into the peripheral vascular interventions market.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
